Sarepta Therapeutics Stock Price History
| SRPT Stock | USD 133.34 4.60 3.33% |
Below is the normalized historical share price chart for Sarepta Therapeutics extending back to June 04, 1997. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sarepta Therapeutics stands at 133.34, as last reported on the 30th of November, with the highest price reaching 138.81 and the lowest price hitting 133.15 during the day.
If you're considering investing in Sarepta Stock, it is important to understand the factors that can impact its price. Currently, Sarepta Therapeutics is very steady. Sarepta Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0052, which indicates the firm had a 0.0052% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Sarepta Therapeutics, which you can use to evaluate the volatility of the company. Please validate Sarepta Therapeutics' Coefficient Of Variation of (9,384), variance of 7.07, and insignificant Risk Adjusted Performance to confirm if the risk estimate we provide is consistent with the expected return of 0.0142%.
At this time, Sarepta Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 97 M in 2024, whereas Capital Stock is likely to drop 9,167 in 2024. . Price Earnings To Growth Ratio is likely to gain to 0.63 in 2024, whereas Price To Sales Ratio is likely to drop 6.81 in 2024. Sarepta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of June 1997 | 200 Day MA 130.0443 | 50 Day MA 122.158 | Beta 0.803 |
Sarepta |
Sharpe Ratio = 0.0052
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SRPT |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sarepta Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sarepta Therapeutics by adding Sarepta Therapeutics to a well-diversified portfolio.
Price Book 10.7905 | Enterprise Value Ebitda 71.4512 | Price Sales 8.0324 | Shares Float 91.2 M | Wall Street Target Price 183.8236 |
Sarepta Therapeutics Stock Price History Chart
There are several ways to analyze Sarepta Stock price data. The simplest method is using a basic Sarepta candlestick price chart, which shows Sarepta Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 27, 2024 | 137.94 |
| Lowest Price | November 15, 2024 | 104.54 |
Sarepta Therapeutics November 30, 2024 Stock Price Synopsis
Various analyses of Sarepta Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sarepta Stock. It can be used to describe the percentage change in the price of Sarepta Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sarepta Stock.| Sarepta Therapeutics Price Daily Balance Of Power | (0.81) | |
| Sarepta Therapeutics Price Rate Of Daily Change | 0.97 | |
| Sarepta Therapeutics Price Action Indicator | (4.94) | |
| Sarepta Therapeutics Accumulation Distribution | 31,705 |
Sarepta Therapeutics November 30, 2024 Stock Price Analysis
Sarepta Stock Price History Data
The price series of Sarepta Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 34.37 with a coefficient of variation of 6.19. The price distribution for the period has arithmetic mean of 124.15. The median price for the last 90 days is 124.89. The company completed stock split (1:6) on 12th of July 2012.| Open | High | Low | Close | Volume | ||
| 11/29/2024 | 137.11 | 138.81 | 133.15 | 133.34 | 777,554 | |
| 11/27/2024 | 130.94 | 138.10 | 130.00 | 137.94 | 2,916,907 | |
| 11/26/2024 | 116.11 | 131.00 | 115.75 | 130.50 | 3,377,180 | |
| 11/25/2024 | 113.06 | 115.30 | 113.00 | 114.65 | 1,367,562 | |
| 11/22/2024 | 110.68 | 114.83 | 110.50 | 114.23 | 913,603 | |
| 11/21/2024 | 110.87 | 111.78 | 109.03 | 110.50 | 917,248 | |
| 11/20/2024 | 110.46 | 111.38 | 108.72 | 110.86 | 1,195,250 | |
| 11/19/2024 | 104.38 | 106.99 | 103.63 | 106.62 | 1,052,024 | |
| 11/18/2024 | 102.88 | 105.98 | 102.16 | 104.67 | 1,229,780 | |
| 11/15/2024 | 108.54 | 108.70 | 102.57 | 104.54 | 1,570,962 | |
| 11/14/2024 | 112.58 | 112.58 | 109.01 | 109.11 | 1,453,228 | |
| 11/13/2024 | 113.63 | 116.30 | 111.53 | 112.48 | 961,893 | |
| 11/12/2024 | 118.00 | 118.73 | 114.12 | 114.32 | 1,110,094 | |
| 11/11/2024 | 121.88 | 122.63 | 117.53 | 117.84 | 1,143,402 | |
| 11/08/2024 | 120.50 | 121.96 | 116.32 | 121.61 | 1,483,804 | |
| 11/07/2024 | 132.40 | 133.00 | 117.52 | 120.42 | 2,393,179 | |
| 11/06/2024 | 126.50 | 128.32 | 122.45 | 127.97 | 1,453,610 | |
| 11/05/2024 | 123.00 | 125.25 | 121.18 | 125.01 | 825,790 | |
| 11/04/2024 | 123.30 | 124.03 | 121.01 | 123.07 | 973,203 | |
| 11/01/2024 | 125.91 | 126.51 | 122.68 | 123.29 | 1,141,422 | |
| 10/31/2024 | 127.32 | 128.19 | 125.92 | 126.00 | 652,347 | |
| 10/30/2024 | 129.32 | 130.85 | 127.40 | 127.78 | 658,067 | |
| 10/29/2024 | 130.07 | 131.17 | 129.26 | 130.21 | 431,757 | |
| 10/28/2024 | 131.37 | 132.80 | 129.26 | 130.26 | 515,932 | |
| 10/25/2024 | 132.10 | 133.36 | 130.93 | 131.14 | 849,647 | |
| 10/24/2024 | 129.90 | 132.88 | 129.53 | 132.02 | 737,633 | |
| 10/23/2024 | 131.00 | 131.00 | 126.78 | 129.88 | 737,353 | |
| 10/22/2024 | 126.26 | 128.54 | 126.21 | 128.42 | 514,391 | |
| 10/21/2024 | 127.73 | 129.24 | 126.58 | 127.31 | 859,173 | |
| 10/18/2024 | 124.98 | 130.04 | 124.26 | 127.08 | 1,028,029 | |
| 10/17/2024 | 125.60 | 127.18 | 124.21 | 124.25 | 895,517 | |
| 10/16/2024 | 123.66 | 126.35 | 123.66 | 125.92 | 612,937 | |
| 10/15/2024 | 124.37 | 124.98 | 123.22 | 123.73 | 656,161 | |
| 10/14/2024 | 124.42 | 124.94 | 122.74 | 124.37 | 414,736 | |
| 10/11/2024 | 122.41 | 125.96 | 122.17 | 124.51 | 868,375 | |
| 10/10/2024 | 119.69 | 124.66 | 118.43 | 122.41 | 1,083,137 | |
| 10/09/2024 | 119.64 | 119.64 | 116.17 | 117.99 | 1,099,448 | |
| 10/08/2024 | 117.86 | 120.89 | 117.53 | 119.72 | 809,027 | |
| 10/07/2024 | 120.32 | 121.00 | 116.58 | 117.79 | 884,154 | |
| 10/04/2024 | 119.91 | 121.88 | 118.63 | 120.40 | 890,683 | |
| 10/03/2024 | 121.96 | 122.22 | 118.27 | 118.76 | 1,381,132 | |
| 10/02/2024 | 121.73 | 124.00 | 119.76 | 122.52 | 822,532 | |
| 10/01/2024 | 125.00 | 125.73 | 121.66 | 122.33 | 723,107 | |
| 09/30/2024 | 124.93 | 127.90 | 123.68 | 124.89 | 676,671 | |
| 09/27/2024 | 125.59 | 125.74 | 123.47 | 124.53 | 768,309 | |
| 09/26/2024 | 124.59 | 125.76 | 123.60 | 124.84 | 582,823 | |
| 09/25/2024 | 125.56 | 125.92 | 123.65 | 124.62 | 716,412 | |
| 09/24/2024 | 125.03 | 125.84 | 123.27 | 125.49 | 628,434 | |
| 09/23/2024 | 127.21 | 127.29 | 124.57 | 124.79 | 753,950 | |
| 09/20/2024 | 127.10 | 129.01 | 125.05 | 127.21 | 997,657 | |
| 09/19/2024 | 126.41 | 128.65 | 125.61 | 127.10 | 636,890 | |
| 09/18/2024 | 126.07 | 128.08 | 123.61 | 125.01 | 624,885 | |
| 09/17/2024 | 124.78 | 127.36 | 124.32 | 125.69 | 528,532 | |
| 09/16/2024 | 125.76 | 126.67 | 123.91 | 124.33 | 670,774 | |
| 09/13/2024 | 124.12 | 125.95 | 120.42 | 124.65 | 1,243,842 | |
| 09/12/2024 | 128.00 | 128.00 | 124.49 | 125.34 | 624,704 | |
| 09/11/2024 | 126.46 | 128.59 | 125.34 | 128.39 | 871,211 | |
| 09/10/2024 | 127.57 | 127.86 | 124.71 | 126.94 | 619,061 | |
| 09/09/2024 | 128.51 | 129.93 | 127.29 | 127.69 | 945,663 | |
| 09/06/2024 | 134.00 | 134.55 | 126.82 | 128.92 | 1,160,484 | |
| 09/05/2024 | 134.84 | 135.27 | 133.22 | 133.77 | 422,992 |
About Sarepta Therapeutics Stock history
Sarepta Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sarepta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sarepta Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sarepta Therapeutics stock prices may prove useful in developing a viable investing in Sarepta Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 92.4 M | 97 M | |
| Net Loss | -633.1 M | -601.5 M |
Sarepta Therapeutics Quarterly Net Working Capital |
|
Sarepta Therapeutics Stock Technical Analysis
Sarepta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Sarepta Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sarepta Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Sarepta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sarepta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.14) | |||
| Total Risk Alpha | (0.48) | |||
| Treynor Ratio | (0.05) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Sarepta Stock Analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.